Alembic Pharmaceuticals standalone net profit declines 57.69% in the June 2017 quarter

Sales decline 15.38% to Rs 590.11 crore

Net profit of Alembic Pharmaceuticals declined 57.69% to Rs 50.66 crore in the quarter ended June 2017 as against Rs 119.74 crore during the previous quarter ended June 2016. Sales declined 15.38% to Rs 590.11 crore in the quarter ended June 2017 as against Rs 697.35 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales590.11697.35 -15 OPM %14.7124.66 -PBDT86.23171.78 -50 PBT64.41152.71 -58 NP50.66119.74 -58

Powered by Capital Market - Live News